TAMRA azide, 5-isomer
| Cat. # | Quantity | Price | Lead time | Buy this product |
|---|---|---|---|---|
| 17130 | 100 uL, 10 mM/DMSO | $110.00 | in stock | |
| 37130 | 500 uL, 10 mM/DMSO | $210.00 | in stock | |
| 47130 | 1 mL, 10 mM/DMSO |
$410.00
|
in stock | |
| A7130 | 1 mg | $110.00 | in stock | |
| B7130 | 5 mg | $210.00 | in stock | |
| C7130 | 10 mg | $310.00 | in stock | |
| D7130 | 25 mg |
$410.00
|
in stock | |
| E7130 | 50 mg |
$695.00
|
in stock | |
| F7130 | 100 mg |
$1190.00
|
in stock |
TAMRA (TMR, tetramethylrhodamine) azide, solid compound, and 10 mM solution in DMSO, labeling reagent for Click Chemistry. Pure 5-isomer.
TAMRA is often used as FRET acceptor for FAM fluorophore.
Can replace Alexa Fluor 555, DyLight 549.
Absorption and emission spectra of 5-TAMRA
Customers also purchased with this product
BDP FL maleimide
BDP FL maleimide is a bright and photostable thiol-reactive dye for protein labeling, an ideal replacement for fluorescein for microscopy.Copper(II)-TBTA complex, 10 mM in 55% aq. DMSO
Catalyst for bioconjugate synthesis by Click Chemistry.Pyrene azide 1
Reagent for fluorescent labeling with pyrene polycyclic aromatic hydrocarbon via Click Chemistry.General properties
| Appearance: | violet solid / solution |
| Mass spec M+ increment: | 512.2 |
| Molecular weight: | 512.56 |
| CAS number: | 825651-66-9 |
| Molecular formula: | C28H28N6O4 |
| Solubility: | good in polar organic solvents (DMF, DMSO, alcohols), low in water |
| Quality control: | NMR 1H, HPLC-MS (95%) |
| Storage conditions: | Storage: 24 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. |
| MSDS: | Download |
Spectral properties
| Excitation maximum, nm: | 541 |
| ε, L⋅mol−1⋅cm−1: | 84000 |
| Emission maximum, nm: | 567 |
| Fluorescence quantum yield: | 0.1 |
| CF260: | 0.32 |
| CF280: | 0.19 |
Product citations
- Li, W.; Zhou, Y.; Tang, G.; Wong, N.-K.; Yang, M.; Tan, D.; Xiao, Y. Chemoproteomics Reveals the Anti-proliferative Potential of Parkinson's Disease Kinase Inhibitor LRRK2-IN-1 by Targeting PCNA Protein. Molecular Pharmaceutics, in press. doi: 10.1021/acs.molpharmaceut.8b00325
- Moynihan, K.D.; Holden, R.L.; Mehta, N.K.; Wang, C.; Karver, M.R.; Dinter, J.; Liang, S.; Abraham, W.; Melo, M.B.; Zhang, A.Q.; Li, N.; Le Gall, S.; Pentelute, B.; Irvine, D.J. Enhancement of peptide vaccine immunogenicity by increasing lymphatic drainage and boosting serum stability. Cancer Immunology Research, in press. doi: 10.1158/2326-6066.CIR-17-0607
- Spangler, B.; Dovala, D.; Sawyer, W.S.; Thompson, K.V.; Six, D.A.; Reck, F.; Feng, B.Y. Molecular probes for the determination of sub-cellular compound exposure profiles in Gram-negative bacteria. ACS Infectious Diseases, in press. doi: 10.1021/acsinfecdis.8b00093
- Nemmara, V.J.; Subramanian, V.; Muth, A.; Mondal, S.; Salinger, A.J.; Maurais, A.J.; Tilvawala, R.; Weerapana, E.; Thompson, P.R. The Development of Benzimidazole-Based Clickable Probes for the Efficient Labeling of Cellular Protein Arginine Deiminases (PADs). ACS Chemical Biology, 2018, 13(3), 712–722. doi: 10.1021/acschembio.7b00957
The count of items is incorrect.
Your cart is empty
$ 
